Status:
RECRUITING
Effectiveness of the WHO ICOPE (Integrated Care for Older People) Program in Preventing Age-related Functional Decline (ICOPE Trial.Fr)
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Ageing
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
The World Health Organization (WHO) has designed an integrated care program (ICOPE) aimed at maintaining the functions of elderly people to preserve their autonomy. It includes four steps (Screening, ...
Detailed Description
ICOPE Trail.Fr is a comparative, multicenter, randomized (1:1), two-arm parallel intervention trial, stratified by center and the number of impairments present at inclusion, open-label, controlled, co...
Eligibility Criteria
Inclusion Criteria:
- Participants aged 65 years and older.
- Participants living independently at home (ADL = 6, except for an occasional urinary abnormality which will be accepted).
- Participants showing functional decline in at least 2 of the 6 functional domains of ICOPE (mobility, cognition, nutrition, vision, hearing, and psychological well-being) identified using the ICOPE screening tool.
- Participants affiliated with a social protection system.
Exclusion Criteria:
- Participants who has already benefited from the ICOPE program or who has completed more than one isolated step 1
- Participants living in a dependent elderly care facility.
- Participants with a disability preventing them from reaching the trial examination center without assistance (such as dementia or significant mobility impairment).
- Participants with hearing, visual, or speech impairments preventing them from understanding instructions or communicating with study staff.
- Participants with a life-threatening illness with a prognosis of less than 5 years.
- Participants unable to provide informed written consent.
- Participants under legal protection, guardianship, or trusteeship.
- Participants participating in another interventional research study.
- Participants in a relationship with a person participating in the study.
Key Trial Info
Start Date :
October 14 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2031
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06676839
Start Date
October 14 2024
End Date
October 31 2031
Last Update
March 23 2026
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
CHIC
Castres, France, France, 81108
2
Perpignan Hospital
Perpignan, France, France, 66046
3
Bigorre Hospital
Tarbes, France, France, 65000
4
CHU Toulouse
Toulouse, France, France, 31000